3 min read

Patient Enrollment Engagement in Indications With Flare-Ups

Don’t let enrollment problems sideline your research.
Recent studies cite that 80% of trials are delayed due to patient recruitment challenges, with up to 20% of enrolled sites never enrolling a single patient.

Recent studies cite that 80% of trials are delayed due to patient recruitment challenges, with up to 20% of enrolled sites never enrolling a single patient. Making recruitment even more challenging is the fact that the number of inclusion/exclusion criteria in protocols has increased by 61%, which greatly increases a study’s screen-fail rate. So imagine if you were running a study where a patient may qualify one day, but not the day of the screening visit as their specified condition became dormant. And then imagine trying to follow-up with those patients and continuously monitoring symptoms in order to enroll them into your clinical trial.

August is Psoriasis Awareness Month. Conditions such as psoriasis (as well as other inflammatory or autoimmune disorders in addition to conditions such as migraine and GI disorders) can have an additional layer of complexity added to patient enrollment—the “flare up”. Many of these patients may pre-qualify for a study, but due to the severity of the disease during the time of the screening visit, may have to wait until they are symptomatic in order to enroll. Many of these patients can leave a study before it even begins, so it is crucial to keep these potential subjects engaged until the time they may be eligible. This is also key for patients who cannot attend visit 1 until a mandatory wash-out period.

UBC’s Patient & Physician Recruitment & Retention Services team can engage this patient population and reduce site burden by conducting the engagement necessary to keep patients interested. This communication can come in the form of outbound calls, emails, instructional video links, and mailings to potential subjects. The aim of this communication is to:

  • Answer any questions patients have about the requirements and potential benefits of the study.
  • Remind patients of screening visits.
  • Remind and instruct patients about at-home procedures.
  • Send supportive/thank you messages to keep patients engaged prior to and during the study.

After successful enrollment into the study, many of these studies also have symptom ratings as part of the patient study requirements via a diary/ePRO device. UBC can provide tools such as descriptive animated videos that assist participants in successfully rating their symptoms and staying engaged in the study.

Looking for patient engagement solutions for your trial? Get in touch with our expert team today.

Other Recent Posts

Press
5 min read

UBC Successfully Implemented REMS Administration Software DuringHL7® FHIR® Connectathon

UBC demonstrated our commitment to optimizing safe medication use and health outcomes by participating in the HL7® FHIR® Connectathon.
Press
5 min read

UBC Selects Oracle Cloud Safety Technology for its Safety Programs

UBC selected Oracle Life Sciences' safety case management solution.
Press
2 min read

UBC Receives CRO Leadership Award Again

UBC was honored as a winner in the 2023 CRO Leadership Awards by both big and small pharma in the Reliability category.

Thank You for Connecting with UBC

Lorem ipsum dolor sit amet consectetur. Mi proin enim ipsum nascetur. Venenatis odio scelerisque non netus ac et pellentesque.

What You Can Expect Next

Lorem ipsum dolor sit amet consectetur. Cras aliquam erat eget magna sollicitudin.

Get Ready to Change Your Business

Lorem ipsum dolor sit amet consectetur. Mi proin enim ipsum nascetur. Venenatis odio scelerisque non netus ac et pellentesque.

Service Request

Bekki Bracken Brown

President & Chief Executive Officer

Bekki Bracken Brown serves as the President and CEO of UBC, guiding the company’s mission and values, including the improvement of access for patients to receive better outcomes. She oversees all aspects of UBC, such as operations, business growth strategy, sales and marketing, and acquisition support.

With over 20 years of industry experience, Ms. Brown brings knowledge from a successful career in senior management from her tenure at Quintiles, INC Research, and, most recently, with Syneos Health. She’s been a member of the North Carolina BIO Board of Directors since 2019. She is also a member of the Healthcare Businesswomen’s Association — Southeast Chapter and CHIEF, an organization that supports women executive leaders. Ms. Brown earned her bachelor’s degree at Duke University.